The Company anticipates filing its NDA for GTx-104 in the second quarter of 2025. Acceptance of the NDA will be subject to the FDA’s review of the complete filing.

IV infusions of antioxidants like Vitamin C and Glutathione have quietly become the new beauty obsession not just in Lagos, ...

Enclara Pharmacia, the nation's leading hospice pharmacy solutions provider, has announced the launch of next-day shipping infusion services. This innovative program addresses a critical gap in ...

IRadimed Corporation offers steady revenue growth with 14 consecutive quarters of record revenue and a small dividend, ...

ICU Medical, Inc. ICUI, yesterday, announced the FDA’s 510(k) clearance for the Plum Solo precision IV pump, a single-channel ...

Cullinan Therapeutics rebranded from oncology to immunology+oncology, focusing on CD19 TCEs for autoimmune diseases. Check ...

ICU Medical (Nasdaq: ICUI) announced today that it received FDA 510(k) clearance for several new additions to its infusion ...

The findings reinforce the potential of BRIUMVI in improving patient outcomes for those seeking an alternative to their previous anti-CD20 therapy. Furthermore, the article in CNS DRUGS offers an ...

Biosimilar challenges include complex manufacturing processes and regulatory obstacles, offset by less regulated market ...

Infusion therapy is a medical treatment where fluids, medications, or nutrients are delivered directly into a patient’s ...

Donald Trump gave Tiger Woods his stamp of approval after the golf champion announced his new relationship with Vanessa Trump, ex-wife of Donald Trump Jr. Val Kilmer, who died April 1 at age 65, ...